Quick Answer
Alzamend Neuro, Inc. reported Total Assets of $4.60 million for fiscal year 2025.
Alzamend Neuro, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $4.60M | +628.8% |
| 2024 | $631.6K | -89.3% |
| 2023 | $5.92M | -59.2% |
| 2022 | $14.52M | +398.4% |
| 2021 | $2.91M | +60.6% |
| 2020 | $1.81M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | $5.09M | +1.7% | -19.5% |
| July 31, 2025 | $6.33M | +278.9% | +37.4% |
| April 30, 2025 | $4.60M | +628.8% | +10.2% |
| January 31, 2025 | $4.18M | +433.5% | -16.6% |
| October 31, 2024 | $5.01M | +409.1% | +199.9% |
| July 31, 2024 | $1.67M | -36.5% | +164.4% |
| April 30, 2024 | $631.6K | -89.3% | -19.3% |
| January 31, 2024 | $782.6K | -90.8% | -20.4% |
- Alzamend Neuro, Inc. showed an increase of +628.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Alzamend Neuro, Inc.’s total assets has grown by 153.7% (from $1.81 million to $4.60 million).
- The most recent figure is from Alzamend Neuro, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: